Abstract
Mulberry leaf, as a traditional Chinese medicine with medicinal and food values, is nowadays widely used in the clinical treatment of diabetes and hyperlipidemia. Its active ingredients are mainly flavonoids, polysaccharides, alkaloids and other substances, which have good efficacy in regulating insulin secretion, hypoglycemia and lipid lowering. In recent years, a large number of experimental studies and some clinical studies have proved that mulberry leaf does have hypoglycemic effect, and it is widely available, easy to obtain and low in price. In this paper, we review the research progress on the mechanisms of mulberry leaf inhibition of α-glucosidase activity, promotion of insulin secretion, improvement of pancreatic islet function, promotion of glucose utilization by peripheral tissues, and enhancement of hepatic glycogen. It is expected to provide guidelines for in-depth research on the mechanism of action of mulberry leaves in regulating blood glucose and preventing diabetic complications, and to provide a basis and reference for the development and utilization of mulberry leaf resources.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.